DRUG · COUNSELLING NOTES
Agalsidase Alfa
Replagal
Updated
New prescription
indication: _____. IV q2 weeks by HCP; report fever, chills during infusion; warned on allergies; serious/common AEs: infusion reactions, headache, nausea; non-pharm: avoid heat/overexertion.
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IV q2 weeks by HCP; report fever, chills during infusion; warned on allergies; serious/common AEs: infusion reactions, headache, nausea; non-pharm: avoid heat/overexertion.